ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
3.530
-0.110 (-3.02%)
Nov 6, 2024, 4:00 PM EST - Market closed
ImmuCell Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 23.22 | 17.47 | 18.57 | 19.24 | 15.34 | 13.72 | Upgrade
|
| Revenue Growth (YoY) | 48.05% | -5.90% | -3.51% | 25.43% | 11.80% | 24.91% | Upgrade
|
| Cost of Revenue | 16.65 | 13.08 | 10.33 | 10.59 | 8.48 | 6.98 | Upgrade
|
| Gross Profit | 6.58 | 4.4 | 8.24 | 8.66 | 6.86 | 6.74 | Upgrade
|
| Selling, General & Admin | 5.45 | 5.22 | 5.45 | 4.23 | 3.89 | 4.01 | Upgrade
|
| Research & Development | 4.48 | 4.39 | 4.49 | 4.17 | 4.35 | 3.69 | Upgrade
|
| Operating Expenses | 9.92 | 9.62 | 9.95 | 8.4 | 8.24 | 7.69 | Upgrade
|
| Operating Income | -3.35 | -5.22 | -1.71 | 0.26 | -1.38 | -0.95 | Upgrade
|
| Interest Expense | -0.59 | -0.48 | -0.35 | -0.31 | -0.41 | -0.43 | Upgrade
|
| Interest & Investment Income | 0.06 | 0.1 | 0.15 | 0.02 | 0.03 | 0.12 | Upgrade
|
| Other Non Operating Income (Expenses) | - | 0 | 0 | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -3.87 | -5.6 | -1.9 | -0.04 | -1.77 | -1.26 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.01 | -0.01 | 0.01 | -0.03 | -0.04 | -0 | Upgrade
|
| Other Unusual Items | -0.53 | -0.53 | -0.59 | - | 0.77 | - | Upgrade
|
| Pretax Income | -4.05 | -5.77 | -2.49 | -0.07 | -1.03 | -1.27 | Upgrade
|
| Income Tax Expense | 0 | 0 | 0.01 | 0.01 | -0.01 | 0.03 | Upgrade
|
| Net Income | -4.05 | -5.77 | -2.49 | -0.08 | -1.02 | -1.3 | Upgrade
|
| Net Income to Common | -4.05 | -5.77 | -2.49 | -0.08 | -1.02 | -1.3 | Upgrade
|
| Shares Outstanding (Basic) | 8 | 8 | 8 | 8 | 7 | 7 | Upgrade
|
| Shares Outstanding (Diluted) | 8 | 8 | 8 | 8 | 7 | 7 | Upgrade
|
| Shares Change (YoY) | 0.23% | 0.03% | 2.01% | 5.25% | 5.78% | 24.29% | Upgrade
|
| EPS (Basic) | -0.52 | -0.75 | -0.32 | -0.01 | -0.14 | -0.19 | Upgrade
|
| EPS (Diluted) | -0.52 | -0.75 | -0.32 | -0.01 | -0.14 | -0.19 | Upgrade
|
| Free Cash Flow | -0.91 | -6.57 | -5.52 | -1.65 | -2.76 | -1.16 | Upgrade
|
| Free Cash Flow Per Share | -0.12 | -0.85 | -0.71 | -0.22 | -0.38 | -0.17 | Upgrade
|
| Gross Margin | 28.32% | 25.16% | 44.37% | 44.98% | 44.73% | 49.11% | Upgrade
|
| Operating Margin | -14.41% | -29.88% | -9.21% | 1.34% | -9.00% | -6.95% | Upgrade
|
| Profit Margin | -17.44% | -33.05% | -13.43% | -0.41% | -6.66% | -9.44% | Upgrade
|
| Free Cash Flow Margin | -3.93% | -37.59% | -29.72% | -8.60% | -17.97% | -8.44% | Upgrade
|
| EBITDA | -0.63 | -2.5 | 0.78 | 2.72 | 0.97 | 1.31 | Upgrade
|
| EBITDA Margin | -2.73% | -14.33% | 4.19% | 14.13% | 6.30% | 9.57% | Upgrade
|
| D&A For EBITDA | 2.71 | 2.72 | 2.49 | 2.46 | 2.35 | 2.27 | Upgrade
|
| EBIT | -3.35 | -5.22 | -1.71 | 0.26 | -1.38 | -0.95 | Upgrade
|
| EBIT Margin | -14.41% | -29.88% | -9.21% | 1.34% | -9.00% | -6.95% | Upgrade
|
| Advertising Expenses | - | - | - | - | 0.03 | 0.06 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.